ArticleThe East African health research journal2025
Ceftriaxone Resistance in the Surgical Adult Intensive Care Unit at Muhimbili National Hospital, Dar es Salaam, Tanzania.
Article in The East African health research journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The resistance to first line agents, namely third generation cephalosporins, specifically ceftriaxone, has been clinically observed in a number of patients at Muhimbili National Hospital (MNH) medical wards. However, there has been no any study from the intensive care units with regards to resistance to ceftriaxone per se. Objective: The objective of our study was to audit the use of ceftriaxone with STG adherence as the first line antibacterial agent on the prophylaxis and treatment of bacterial infections among patients admitted in the surgical Adult Intensive Care Unit (AICU) at MNH, Dar es Salaam, Tanzania. Methods: This was a prospective descriptive cross-sectional clinical audit study, done from January, 2021 to December, 2021. Results were analyzed using SPSS 23. Results: During one year of the study period, a total of 735 patients were admitted in the surgical MNH-AICU with different clinical diagnosis. A total of 731 (99.50%) were included in the final analysis, with only 75 (10.26%) having culture and sensitivity performed on them. Among all isolates, Conclusion: In this study, the majority of pathogens were due to multi-drug resistant (MDR) bacteria. The STG adherence was very low with regard to the use of ceftriaxone (4.30%). The resistance to Ceftriaxone was 100%; thus, Ceftriaxone should no longer be used as the first line for prophylaxis and treatment of bacterial infections in the surgical MNH-AICU and similar settings. Crucially, the establishment of dedicated Antimicrobial Stewardship Program (ASP) teams, along with rigorous education and strict adherence to defined guidelines, is of paramount importance to counteract and effectively reduce the observed antimicrobial resistance (AMR) burden.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.